.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India recently launched its national HPV vaccination campaign to combat cervical cancer among adolescent girls. Prime Minister Narendra Modi inaugurated the initiative in Ajmer, Rajasthan. This landmark step reflects India's strong commitment to women's health. Consequently, the World Health Organization (WHO) congratulated the nation on this massive public health milestone. The move signals a decisive shift in the country's public health journey.
The program targets approximately 1.15 crore girls aged 14 every year. Therefore, it aims to reduce the heavy burden of cervical cancer in the region significantly. Currently, cervical cancer claims a woman's life every two minutes globally. India carries nearly one-quarter of this global burden. Specifically, the government will provide the vaccine free of cost at designated facilities. This ensures equity and protection for all daughters of the country.
Furthermore, this rollout aligns with the global 90-70-90 targets for 2030. These targets involve vaccinating 90% of girls by age 15. Additionally, they include screening 70% of women twice by ages 35 and 45. Finally, 90% of women with cervical disease must receive appropriate treatment. India's effort will accelerate regional momentum toward eliminating this disease as a public health problem.
Q1: Who is the target audience for the HPV vaccination campaign?
The campaign primarily targets approximately 1.15 crore girls aged 14 years across all States and Union Territories annually.
Q2: Is the HPV vaccine provided for free in India?
Yes, the vaccine is provided free of cost at designated Government health facilities as part of this national initiative.
Q3: What are the WHO 90-70-90 targets mentioned?
The 2030 targets aim to vaccinate 90% of girls by age 15, screen 70% of women, and treat 90% of those with cervical cancer or pre-cancer.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India launches a national HPV vaccination campaign targeting 1.15 crore girls annually to eliminate cervical cancer and meet WHO global targets by 2030....
7 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
